Risk of Malignancy Index (RMI) — Adnexal Mass

ورودی‌های بالینی بیمار

حداقل ۰ — حداکثر ۳

حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: U/mL

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
rmi
—index
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low risk0–200
  • High risk≥ 200.1
Direct Clinical Answer

The Risk of Malignancy Index (RMI) — Adnexal Mass calculates calculating gestational age, evaluating maternal-fetal wellbeing, and assessing perinatal complications. Key inputs include u score. Scores guide determining delivery timing, administering antenatal corticosteroids or tocolytics, and obstetric monitoring. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Risk of Malignancy Index (Jacobs 1990) for adnexal masses: RMI = ultrasound score × menopausal score × CA-125 (U/mL). U: 0 (no features), 1 (1 feature), 3 (≥2 features) — features: multilocular cyst, solid areas, bilaterality, ascites, metastases. M: 1 premenopausal, 3 postmenopausal. RMI >200 = high risk of malignancy.

Clinical Indication

The Risk of Malignancy Index (RMI) — Adnexal Mass is indicated for bedside clinical practice to support Risk of Malignancy Index (Jacobs 1990) for adnexal masses: RMI = ultrasound score × menopausal score × CA-125 (U/mL). U: 0 (no features), 1 (1 feature), 3 (≥2 features) — features: multilocular cyst, solid areas, bilaterality, ascites, metastases. M: 1 premenopausal, 3 postmenopausal. RMI >200 = high risk of malignancy.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Pregnant individuals across antepartum, intrapartum, and postpartum stages, or patients with acute gynecologic conditions. Clinical application is indicated across Labor and delivery suites, obstetric triage, antenatal clinics, and gynecologic surgical units.

Limitations & Contraindications

Normal gestational physiological adaptations alter baseline plasma volume, serum creatinine, and resting heart rate.

Clinical Pearls & Action Plan

Simultaneous surveillance of maternal hemodynamic stability and continuous electronic fetal heart rate monitoring is paramount.

Formula & Variables:

RMI = U × M × CA-125.

Input Parameters

NameTypeRequiredDescription
u_scoreintegerYesUltrasound score U (0, 1, or 3)
menopausalstringYesMenopausal status
ca125floatYesCA-125 level(U/mL)

Score Interpretation & Guidance

RangeStageDescription
0–200Low riskLow risk
≥ 200.1High riskHigh risk

Evidence-Based References (EBM)

  • Jacobs I, Oram D, Fairbanks J, et al. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol. 1990;97(10):922-929.

Related calculators